Huyabio International has appointed Paul Spreen as Chief Business Officer.

“We are delighted to welcome Paul Spreen to the HUYA executive team,” said Dr. Mireille Gillings, President, CEO & Executive Chair at Huyabio. “His global management and business development expertise will be invaluable as we continue to deliver on our mission of meeting tomorrow’s unmet medical needs.”

Prior to joining Huyabio, Spreen served as Chief Commercial Officer at IQVIA, a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. In this role, he oversaw the go-to-market growth strategy for R&D and Commercial businesses, driving enterprise ownership of accounts globally.

He joined Quintiles in 1996 serving in a variety of increasingly senior customer-focused roles within the company’s clinical development organization including President, Customer Solutions Management Group and Chief Customer Officer, working directly with senior-level clients to develop groundbreaking enterprise-level opportunities across the portfolio. Spreen studied Biology at Northeastern University.